Icosavax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	767	317	893	-	-
Market Cap Growth	207.74%	-64.53%	-	-	-
Enterprise Value	546	106	613	-11	-23
PE Ratio	-	-3.45	-13.34	-	-
PS Ratio	-	544.35	114.49	-	-
PB Ratio	3.30	1.45	3.21	-	-
P/FCF Ratio	-5.26	-4.35	-22.59	-	-
P/OCF Ratio	-5.63	-5.14	-23.18	-	-
EV/Sales Ratio	-	182.54	78.51	-6.53	-
EV/EBITDA Ratio	-1.75	-1.14	-9.18	0.57	4.28
EV/EBIT Ratio	-1.70	-1.12	-9.17	0.57	4.28
EV/FCF Ratio	-2.26	-1.46	-15.49	0.74	5.05
Debt / Equity Ratio	0.03	0.04	-	-0.19	-
Debt / EBITDA Ratio	-0.08	-0.09	-	-0.27	-
Debt / FCF Ratio	-0.11	-0.12	-	-0.35	-
Quick Ratio	17.59	15.91	30.39	2.66	18.87
Current Ratio	18.06	16.24	31.02	2.77	19.04
Asset Turnover	0	0.00	0.04	0.08	-
Interest Coverage	-	-	-442.52	-55.96	-
Return on Equity (ROE)	-43.10%	-38.80%	-53.70%	107.90%	-
Return on Assets (ROA)	-39.50%	-36.00%	-32.20%	-95.60%	-
Return on Capital (ROIC)	-44.04%	-41.88%	-23.67%	86.00%	65.49%
Earnings Yield	-12.61%	-28.96%	-7.50%	-	-
FCF Yield	-9.61%	-22.98%	-4.43%	-	-
Buyback Yield / Dilution	-25.87%	-121.11%	-700.18%	65.98%	-
Total Shareholder Return	-25.87%	-121.11%	-700.18%	65.98%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).